‹ Back

Illumina is a global leader in genomics, developing advanced technologies for DNA analysis that enable scientific research, clinical diagnostics, and the advancement of personalized medicine. Its solutions are designed to deliver high accuracy, scalability, and efficiency in genetic analysis.

Key Areas and Solutions

Genomics and Sequencing
Focus: development of DNA sequencing technologies and large-scale genetic analysis.
Key products:

• Next-Generation Sequencing (NGS) systems for comprehensive genomic studies.
• Reagents, flow cells, and library preparation kits.
• Targeted sequencing solutions (exome, RNA, and custom panels).

Ideal for: genetic research, oncology, rare and infectious diseases.

Microarrays and Genotyping
Focus: analysis of genetic variation using high-throughput array technologies.
Key products:

• Microarrays for population studies and large-scale genotyping.
• Applications in pharmacogenomics and genome-wide association studies.

Ideal for: population studies, academic research, and pharmaceutical development.

Diagnostics and Precision Medicine
Focus: clinical application of genomics to improve diagnosis and treatment.
Key products:

• Sequencing-based tests for oncology and genetic diseases.
• Non-invasive prenatal testing (NIPT) solutions.

Ideal for: hospitals, clinical laboratories, and personalized medicine.

Values and Approach

• Continuous innovation in genomic technologies.
• Commitment to improving human health through genomic insights.
• Global collaboration with researchers, institutions, and healthcare systems.
• Development of scalable, accessible, and high-quality solutions.